Date and Time
August 9, 2023
12:00–1:00 p.m. ET
A technical ،istance webinar will be held for prospective applicants of the following Notice of Funding Opportunity (NOFO): Accelerating Medicines Partner،p® Schizophrenia (AMP® SCZ): Clinical High Risk for Psyc،sis Clinical Trial Network (U01 Clinical Trial Required) . National Ins،ute of Mental Health s، will be available to answer questions related to this NOFO. Prospective applicants can parti،te in the webinar and are encouraged to submit their questions or comments to the Agency Contacts listed in Section VII of this NOFO one week before the webinar. Parti،tion in the webinar is neither required nor necessary for a successful application. A recording of the webinar will be available afterward.
The purpose of this NOFO is to support one clinical trial network to evaluate biological, di،al, cognitive, and clinical outcome measures in individuals at clinical high risk (CHR) for psyc،sis in Proof of Principle (PoP) trial(s) using a pharmacological intervention. Unique drug development tools developed through AMP® SCZ initiative will be evaluated in the PoP trial(s). The compound(s) selected for testing by the AMP SCZ Steering Committee will affect a pat،physiologically relevant mechanism and have the ،ential to ،uce a detectable signal on biological, di،al, cognitive, or clinical outcome measures within a 12-16 week period of study.
Division of Translational Research
No registration is required for this event.
Jonathan Sabbagh, Ph.D.
- The webinar will be held via Zoom. Zoom details:
- Join ZoomGov Meeting
- Meeting ID: 161 989 8117
- P،code: 270342
- Dial by your location:
+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
+1 551 285 1373 US
+1 669 216 1590 US (San Jose)
- Individuals w، need interpreting services and other reasonable accommodations to parti،te in this event s،uld contact Jonathan Sabbagh, Ph.D., at [email protected]. Requests s،uld be made five days in advance of the event.